Molecular Partners AG (SWX:MOLN)

Molecular Partners AG Balance Sheet

Financials in millions CHF. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	57.49	82.65	63.87	67.31	87.95	71.81
Short-Term Investments	-	10.41	85.57	119.58	161.2	61
Cash & Short-Term Investments	57.49	93.06	149.44	186.89	249.14	132.81
Cash Growth	-44.99%	-37.73%	-20.04%	-24.99%	87.59%	-23.55%
Accounts Receivable	1.57	0.25	0.29	0.3	0.52	23.71
Other Receivables	-	1.05	0.82	1.45	1	1.99
Receivables	1.57	1.3	1.11	1.75	1.53	25.7
Prepaid Expenses	-	1.91	2.25	2.49	3.91	5.65
Other Current Assets	1.67	0.6	1.48	1.34	0.17	0.02
Total Current Assets	60.73	96.88	154.28	192.46	254.75	164.19
Property, Plant & Equipment	3.79	5.23	4.2	5.68	7.24	8.15
Other Intangible Assets	-	0	0.05	0.21	0.27	0.33
Total Assets	64.52	102.11	158.53	198.35	262.26	172.67

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	1.21	0.94	0.68	0.41	1	4.86
Accrued Expenses	6.99	8.88	8.89	8.47	8.65	12.5
Current Portion of Leases	1.21	1.21	1.22	1.21	1.2	1.19
Current Unearned Revenue	-	-	-	4.33	6.41	28.31
Other Current Liabilities	-	-0	-	-	-	-
Total Current Liabilities	9.41	11.03	10.79	14.42	17.25	46.87
Long-Term Leases	1.53	2.44	1.23	2.44	3.65	4.85
Long-Term Unearned Revenue	-	-	-	-	3.64	6.93
Pension & Post-Retirement Benefits	2.76	8.15	4.88	5.06	2.55	6.74
Other Long-Term Liabilities	0.16	0.16	-	-	-	-
Total Liabilities	13.85	21.77	16.89	21.92	27.09	65.38

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	4.04	4.04	4.04	3.64	3.6	3.23
Additional Paid-In Capital	391.94	389.18	384.88	365.53	360.32	355.01
Retained Earnings	-344.07	-311.75	-246.29	-191.76	-127.78	-250.95
Treasury Stock	-1.24	-1.13	-0.98	-0.98	-0.98	-
Shareholders' Equity	50.66	80.33	141.64	176.43	235.17	107.29
Total Liabilities & Equity	64.52	102.11	158.53	198.35	262.26	172.67

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	2.74	3.64	2.44	3.65	4.85	6.04
Net Cash (Debt)	54.75	89.41	147	183.24	244.29	126.77
Net Cash Growth	-46.84%	-39.17%	-19.78%	-24.99%	92.70%	-23.86%
Net Cash Per Share	1.45	2.40	4.32	5.59	7.34	4.09
Filing Date Shares Outstanding	38.34	37.41	36.86	32.85	32.54	32.15
Total Common Shares Outstanding	38.34	37.41	36.86	32.85	32.54	32.15
Working Capital	51.32	85.85	143.5	178.04	237.5	117.33
Book Value Per Share	1.32	2.15	3.84	5.37	7.23	3.34
Tangible Book Value	50.66	80.33	141.59	176.22	234.9	106.96
Tangible Book Value Per Share	1.32	2.15	3.84	5.36	7.22	3.33
Machinery	-	12.44	12.21	11.77	11.69	10.66
Leasehold Improvements	-	0.63	0.63	0.63	0.62	0.61

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 11, 2026

Data Sources Report a data error